提奥他林通过抑制NF-κB通路和依赖醇的透硫化减轻人体红细胞中TNF-α诱导的炎症
Alessia Mariano1, Irene Bigioni1, Alessia Baseggio Conrado2
1Department of Biochemical Sciences, Sapienza University of Rome, P.le Aldo Moro, 5, 00185 Roma, Italy.
International journal of molecular sciences
|October 29, 2025
概括
硫化是一种天然化合物,通过释放硫化 (H2S) 来减少骨关节炎的炎症. 它抑制了关键的炎症标志物和NF-κB激活在软质细胞中,显示了治疗潜力.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 骨关节炎与硫化 (H2S) 水平降低有关,影响炎症,氧化应激和疼痛.
- 硫氨酸是一种天然的硫化合物,可以通过透硫化捐赠H2S.
研究的目的:
- 为了研究蒂奥林在人类初级红细胞中的抗炎作用.
- 评估蒂奥他林对促炎性细胞因子表达和NF-κB通路激活的影响.
主要方法:
- 在TNF-α刺激之前,人类初级红细胞被提奥林预先治疗.
- 测量了介质素 (IL-6,IL-8,IL-1β) 的mRNA和蛋白质水平.
- 通过免疫光分析NF-κB通路的激活 (p65光和转位).
- 细胞内硫化物水平被量化.
主要成果:
- 提奥林治疗前显著减弱了TNF-α诱导的IL-6,IL-8和IL-1β的上调.
- 硫氨酸抑制了p65酸化和核转位,抑制了NF-κB的激活.
- 提奥林治疗增加了细胞内硫化物水平.
结论:
- 硫氨酸在软质细胞中表现出显著的抗炎性质.
- 它释放H2S和调节炎症通路的能力表明,它有可能作为治疗骨关节炎和相关炎症状况的治疗剂.
相关概念视频
T Cell Types and Functions
2.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.1K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
478
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
478
NF-κB-dependent Signaling Pathway
9.8K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.8K
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
Inflammatory Response
15.9K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
15.9K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
480
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
480


